Our Pipeline
TB Alliance manages the largest pipeline of new TB drugs in history.
The Senior Director of Communications and External Affairs is a new role in the TB Alliance, with the successful candidate expected to manage the Communications function and actively contribute to the policy and advocacy work of the Alliance. She/he will be responsible for developing a proactive and responsive communications strategy that positions the Alliance as the leader in TB drug Research and Development (R&D) and Market Access with a compelling mission and a credible support-worthy partner. This strategy must be effective for multiple audiences including industry, public and private sector researchers, philanthropic and private donors, policy makers, government donors, media, global health advocates, TB experts, prospective employees, physicians and patients.
The objective of the Communications & External Affairs function is to enable the achievement of TB Alliance’s long-term goals, which includes broadening the base of financial support for the mission, enhancing our international leadership position in TB Drug R&D and Market Access and ensuring that external stakeholders are aware of our research and development work.
The successful candidate must bring a strong policy background that would enable her/him to lead communication efforts to help ensure the best policy outcomes for TB Alliance. This will encompass an ability to work with a diverse set of global health stakeholders across the spectrum of interests for the Alliance. As in all the work of TB Alliance, partnership and leveraging collaborations with a wide range of partners is essential for our success.
Furthermore, a critical factor in achieving success includes the skill to grasp scientific concepts and the underlying regulatory environment and helping to translate this into an effective overall communications strategy.
This role reports to the Senior Vice President (SVP) of External Affairs, will collaborate closely with the wider External Affairs team (encompassing Resource Mobilization, Community Engagement and Communications) as well as managing a small Communications team. This individual will provide leadership and oversight to all aspects of communications as well as participating, where appropriate, in representing the Alliance in policy discussions around TB and TB research and development and marketing of its products.
Position preferably located in New York, NY or Washington, DC. Other locations may be considered. Up to 30% travel, including international travel, may be required. TB Alliance is an Equal Employment Opportunity employer.
As part of our overall compensation package, we offer comprehensive health benefits, generous retirement contributions, and work/life flexibility designed to support you and your family.
Starting salary is expected to be in the range of US$192,000 - $240,000 exact salary will be commensurate with skills and experience and adjusted to reflect local currency for candidates outside the US.
Along with a competitive salary, TB Alliance offers superior employee benefits centered on medical insurance with very low co-payments, high levels of coverage, resulting in overall coverage valued at the 95th percentile. The package also includes vision, and dental insurance for employees, spouses, domestic partners, and dependent children, life insurance/accidental death. 100% of employee benefit costs are paid by the organization, with coverage effective day one of employment.
TB Alliance also offers a retirement savings program in the form of a 401k plan with generous employer contributions and employee matching.
Additionally, TB Alliance provides generous paid time-off, paid parental leave, paid family leave, flexible-hybrid work schedules, tuition reimbursement, student loan repayment assistance, as well as professional development opportunities for all staff.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.
TB Alliance manages the largest pipeline of new TB drugs in history.